Warfarin Monitoring in Antiphospholipid Syndrome and Lupus Anticoagulant

@article{Crowl2014WarfarinMI,
  title={Warfarin Monitoring in Antiphospholipid Syndrome and Lupus Anticoagulant},
  author={Ashley N Crowl and A. Schullo-Feulner and J.-Y. Moon},
  journal={Annals of Pharmacotherapy},
  year={2014},
  volume={48},
  pages={1479 - 1483}
}
Objective: To review the available literature on international normalized ratio (INR) and chromogenic factor X (CFX) monitoring in patients with antiphospholipid syndrome (APS), specifically lupus anticoagulant (LA), and furthermore, to identify benefits of one monitoring test compared with the other in the presence of LA. Data Sources: A literature search was conducted through MEDLINE (1946-May 2014) utilizing the following MeSH terms chromogenic compounds, anticoagulants, and factor X… Expand
Use of direct oral anticoagulants in antiphospholipid syndrome
Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome
Anticoagulation in a patient with antiphospholipid syndrome and a mechanical heart valve: a case study.
...
1
2
3
...

References

SHOWING 1-10 OF 25 REFERENCES
Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy
Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients
...
1
2
3
...